Small cell lung cancer (Homo sapiens)
From WikiPathways
Description
Small cell lung carcinoma (SCLC) is a highly malignant cancer of the lung.
Genes altered in small cell lung carcinoma:
- TP53 is mutated in 70-90% of SCLCs.
- RB1 is inactivated in most SCLCs.
- PTEN is mutated in 2-10% of SCLCs.
- MYC amplifications and amplification of MYC family members is found in 30% of SCLCs.
- FHIT protein expression is lost due to Loss of heterozygocity (LOH) on chromosome arm 3p found in more than 80% of SCLCs.
This description was adapted from [Wikipedia](https://en.wikipedia.org/wiki/Small-cell_carcinoma).
Phosphorylation sites were added based on information from PhosphoSitePlus (R), www.phosphosite.org.Please use the New WikiPathways
View approved pathways at the new wikipathways.org. This website will shutdown soon.Quality Tags
Ontology Terms
Bibliography
- Hornbeck PV, Zhang B, Murray B, Kornhauser JM, Latham V, Skrzypek E; ''PhosphoSitePlus, 2014: mutations, PTMs and recalibrations.''; Nucleic Acids Res, 2015 PubMed Europe PMC Scholia
- ''KEGG small cell lung cancer''; https://www.kegg.jp/dbget-bin/www_bget?pathway+map05222,
- Deng WG, Nishizaki M, Fang B, Roth JA, Ji L; ''Induction of apoptosis by tumor suppressor FHIT via death receptor signaling pathway in human lung cancer cells.''; Biochem Biophys Res Commun, 2007 PubMed Europe PMC Scholia
History
View all... |
External references
DataNodes
| View all... |
Annotated Interactions
No annotated interactions
Saving...

